Tuersunayi Abudureheman
Shanghai, 200127, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Construction of Switch Modules for CAR-T Cell Treatment Using a Site-Specific Conjugation System.
Journal: Bioconjugate chemistry
Published: April 25, 2024
Construction of a versatile fusion protein for targeted therapy and immunotherapy.
Journal: Protein science : a publication of the Protein Society
Published: October 17, 2023
CAR-Aptamers Enable Traceless Enrichment and Monitoring of CAR-Positive Cells and Overcome Tumor Immune Escape.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: August 10, 2023
A novel His-tag-binding aptamer for recombinant protein detection and T cell-based immunotherapy.
Journal: Talanta
Published: February 13, 2023
Anti-CD79b/CD3 bispecific antibody combined with CAR19-T cells for B-cell lymphoma treatment.
Journal: Cancer immunology, immunotherapy : CII
Published: January 28, 2023
CDK9 Inhibitor Induces the Apoptosis of B-Cell Acute Lymphocytic Leukemia by Inhibiting c-Myc-Mediated Glycolytic Metabolism.
Journal: Frontiers in cell and developmental biology
Published: December 14, 2020
Bromodomains and Extra-Terminal (BET) Inhibitor JQ1 Suppresses Proliferation of Acute Lymphocytic Leukemia by Inhibiting c-Myc-Mediated Glycolysis.
Journal: Medical science monitor : international medical journal of experimental and clinical research
Published: April 09, 2020
Showing 1-8 of 8
Last Updated: 09/26/2026